Article Details

Lilly announces results from SURPASS programme for T2D and obesity therapy Mounjaro

Retrieved on: 2022-06-20 15:33:28

Tags for this article:

Click the tags to see associated articles and topics

Lilly announces results from SURPASS programme for T2D and obesity therapy Mounjaro. View article details on hiswai:

Excerpt

Recent post hoc analysis of data from the SURPASS 2 and SURPASS 3 trials evaluated the median time to achieve certain glycemic targets (median ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up